Protagonist and Takeda Announce ASCO Plenary Presentation Highlighting Full 32-Week Results from Phase 3 VERIFY Study of Rusfertide, Showing Reductions in Phlebotomy, Improved Hematocrit Control in Polycythemia Vera oggi, 14:02 ansa.it 0 0
Stellantis top a Piazza Affari post Trump. Elkann fa mea culpa, mentre esplode rabbia per compenso Tavares 15/04/2025, 18:20 money.it 0 0
Nessun commento